EUVIMED · CrossrefJournal
Cell Investigation
ISSN 3050-5380 · Elsevier BV
Latest articles
Corrigendum to “Synthetic cell model reveals the coupling of ecDNA maintenance and genomic instability” [Cell Investig. 2 (2026) 100076]
Beyond ADCs: Antibody-encapsulated drug for targeted cancer therapy
Clonal hematopoiesis as a context-dependent modifier of organ-specific disease: Evidence, mechanisms, and translational boundaries
Corrigendum to “RNA helicase DDX21 sustains hematopoietic stem cell homeostasis by preventing nucleolar stress” [Cell Invest. 2 (2026) 100060]
Synthetic cell model reveals the coupling of ecDNA maintenance and genomic instability
Lactylation in concert with other post-translational modifications: Regulatory networks and disease implications
Lycium barbarum polysaccharide suppresses uridine induced malignant progression of lung adenocarcinoma via UPP1 regulation
Navigating glucocorticoid resistance: From GR isoforms to nuclear condensates
RNA helicase DDX21 sustains hematopoietic stem cell homeostasis by preventing nucleolar stress
Integrating genomic landscape and patient-derived organoids to uncover therapeutic vulnerabilities in breast cancer brain metastases
Dual immune checkpoint blockade strategies for cancer therapy
Natural killer cell immunotherapies beyond cancer
Targeting ferroptosis in cancer therapy: Mechanisms, strategies, and clinical applications
Activation of the NRF2 signaling pathway mitigates arthrofibrosis by suppressing myofibroblast ferroptosis through oxidative stress regulation
The function and mechanisms of action of non-coding RNAs in prostatic diseases
RNA m6A modification: a key regulator in normal and malignant processes
Multi-omics advances for molecular characterization, precision medicine, and prognostic implications in leukemia
The role of YTHDF2 in anti-tumor immunity
Advances in cancer treatment: The role of new technologies and research
RNA-binding protein Roq modulates the Drosophila STING antiviral immune response
Antioxidant dipeptide, cyclo (Phe-Phe), protects against bone dysplasia by suppression of phospholipid peroxidation
Increased co-expression of CTLA4/LAG3 predicted adverse clinical outcomes in patients with T-cell malignancies
The molecular and immune microenvironmental landscape of brain metastases: Implications for novel treatment options
Targeting GPX4 degradation through disulfiram: A novel mechanism for ferroptosis induction in leukemia cells
ZDHHC9 mediates SMURF2 palmitoylation to promote lipid synthesis
Clarifying AI’s role in academic writing
Targeting USP10–FAK pathway sensitizes BCR-ABL+ leukemia cells to tyrosine kinase inhibitors
Endogenous double-stranded RNA: Bridging immune activation and cancer therapeutics
Deciphering the role of liver metabolic enzymes in dementia pathogenesis
Oncolytic virotherapy offers hope for high-grade glioma treatment
EUVIMED